Pulse Biosciences, Inc. (NASDAQ: PLSE) today announced the initiation of a clinical feasibility study using its novel Nano-Pulse Stimulation™ (NPS™) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE